Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-06-20T12:21:16.252Z Has data issue: false hasContentIssue false
  • English
  • Français

Methicillin-Resistant Staphylococcus aureus Bloodstream Infection Surveillance: National Healthcare Safety Network’s Laboratory-Identified Event Reporting versus Traditional Laboratory-Confirmed Bloodstream Infection Surveillance

Published online by Cambridge University Press:  10 May 2016

Arthur W. Baker ,
Michael J. Durkin ,
Kristen V. Dicks ,
Sarah S. Lewis ,
Rebekah W. Moehring ,
Luke F. Chen ,
Daniel J. Sexton  and
Deverick J. Anderson
Arthur W. Baker*
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina
Michael J. Durkin
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina
Kristen V. Dicks
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina
Sarah S. Lewis
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina
Rebekah W. Moehring
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina Durham Veterans Affairs Medical Center, Durham, North Carolina
Luke F. Chen
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina
Daniel J. Sexton
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina
Deverick J. Anderson
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina; Duke Infection Control Outreach Network, Durham, North Carolina; and Duke Program for Infection Prevention and Healthcare Epidemiology, Durham, North Carolina
*
Duke University Medical Center, Box 102359, Room 181, Hanes House, Durham, NC 27710 (arthur.baker@dm.duke.edu).
Get access Rights & Permissions [Opens in a new window]

Abstract

Hospitals must report cases of methicillin-resistant Staphylococcus aureus bloodstream infection (BSI) using a new laboratory-identified (LabID) event reporting module. BSI rates obtained using LabID differ from rates of BSI obtained from traditional surveillance (concordance of healthcare facility–onset cases, 61%–76%) because definitions used to report LabID events are inconsistent with traditional BSI definitions

Infect Control Hosp Epidemiol 2014;35(10):1286–1289

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 10 , October 2014 , pp. 1286 - 1289
Copyright
© 2014 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Centers for Disease Control and Prevention (CDC). Operational Guidance for Acute Care Hospitals to Report Facility-Wide Inpatient (FacWideIN) Methicillin-Resistant Staphylococcus aureus (MRSA) Blood Specimen (Bacteremia) Laboratory-Identified (LabID) Event Data to CDC’s NHSN for the Purpose of Fulfilling CMS’s Hospital Inpatient Quality Reporting (IQR) Requirements. Atlanta: CDC, 2012. http://www.cdc.gov/nhsn/PDFs/mrsa-cdi/FINAL-ACH-MRSA-Bacteremia-Guidance.pdf. Accessed January 13, 2014.Google Scholar
2. Centers for Disease Control and Prevention (CDC). Multidrug-Resistant Organism and Clostridium difficile Infection (MDRO/CDI) Module. Atlanta: CDC, 2014. http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO_CDADcurrent.pdf. Accessed January 13, 2014.Google Scholar
3. Centers for Disease Control and Prevention (CDC). LabID Event FAQs. Atlanta: CDC, 2013. http://www.cdc.gov/nhsn/PDFs/faqs/psc/labID-PSC-FAQ-ver5–7.pdf. Accessed December 28, 2013.Google Scholar
4. Centers for Disease Control and Prevention (CDC). CDC/NHSN Surveillance Definitions for Specific Types of Infections. Atlanta: CDC, 2014. http://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf. Accessed January 13, 2014.Google Scholar
5. Anderson, DJ, Miller, BA, Chen, LF, et al. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol 2011;32(4):315–322.Google Scholar
6. Chihara, S, Popovich, KJ, Weinstein, RA, Hota, B. Staphylococcus aureus bacteriuria as a prognosticator for outcome of Staphylococcus aureus bacteremia: a case-control study. BMC Infect Dis 2010;10:225.Google Scholar